DE69020138D1 - Mikroorganismus zur selektiven Herstellung einer spezifischen Komponente von Avermectin und Verfahren zu deren selektiven Herstellung. - Google Patents

Mikroorganismus zur selektiven Herstellung einer spezifischen Komponente von Avermectin und Verfahren zu deren selektiven Herstellung.

Info

Publication number
DE69020138D1
DE69020138D1 DE69020138T DE69020138T DE69020138D1 DE 69020138 D1 DE69020138 D1 DE 69020138D1 DE 69020138 T DE69020138 T DE 69020138T DE 69020138 T DE69020138 T DE 69020138T DE 69020138 D1 DE69020138 D1 DE 69020138D1
Authority
DE
Germany
Prior art keywords
avermectin
selective production
microorganism
specific component
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69020138T
Other languages
English (en)
Other versions
DE69020138T2 (de
Inventor
Satoshi Omura
Haruo Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato Institute
Original Assignee
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Institute filed Critical Kitasato Institute
Application granted granted Critical
Publication of DE69020138D1 publication Critical patent/DE69020138D1/de
Publication of DE69020138T2 publication Critical patent/DE69020138T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C12N15/03—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69020138T 1990-03-05 1990-08-10 Mikroorganismus zur selektiven Herstellung einer spezifischen Komponente von Avermectin und Verfahren zu deren selektiven Herstellung. Expired - Fee Related DE69020138T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2053411A JP2888586B2 (ja) 1990-03-05 1990-03-05 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法

Publications (2)

Publication Number Publication Date
DE69020138D1 true DE69020138D1 (de) 1995-07-20
DE69020138T2 DE69020138T2 (de) 1995-12-14

Family

ID=12942087

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020138T Expired - Fee Related DE69020138T2 (de) 1990-03-05 1990-08-10 Mikroorganismus zur selektiven Herstellung einer spezifischen Komponente von Avermectin und Verfahren zu deren selektiven Herstellung.

Country Status (10)

Country Link
US (2) US5206155A (de)
EP (1) EP0445460B1 (de)
JP (1) JP2888586B2 (de)
AT (1) ATE123805T1 (de)
AU (1) AU629966B2 (de)
CA (1) CA2023114C (de)
DE (1) DE69020138T2 (de)
DK (1) DK0445460T3 (de)
ES (1) ES2075881T3 (de)
NZ (1) NZ234741A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
IT1255135B (it) * 1992-05-05 1995-10-20 Principio attivo a base di avermectine, ceppo e procedimento per la sua preparazione e composizione veterinaria che lo contiene.
US5292647A (en) * 1992-11-30 1994-03-08 Eli Lilly And Company Strain of streptomyces for producing avermectins and processes therewith
DE69415675T2 (de) * 1993-07-23 1999-05-20 Pfizer Verfahren zur Ausfällung von natürlichen Avermectinen, sowie Fermentationsverfahren zur Herstellung derselben
BR9907893A (pt) * 1998-02-13 2000-11-14 Pfizer Prod Inc Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1
US6605595B1 (en) 1999-02-09 2003-08-12 The Kitasato Institute Avermectin derivatives
JP2000245457A (ja) 1999-02-24 2000-09-12 Kitasato Inst:The エバーメクチンアグリコン合成酵素遺伝子
JPWO2002012261A1 (ja) 2000-08-09 2004-01-15 社団法人北里研究所 エバーメクチン誘導体
CA2418975C (en) 2000-08-09 2012-01-17 Satoshi Omura Avermectin derivatives
CN101429536B (zh) * 2008-12-15 2011-09-14 浙江升华拜克生物股份有限公司 一种采用全孢子接种工艺生产阿维菌素的方法
MX2016011367A (es) * 2014-03-10 2017-02-02 Zhejiang Hisun Pharm Co Ltd Microorganismo recombinante que expresa analogos de avermectina y uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
IN167980B (de) * 1987-01-23 1991-01-19 Pfizer
ES2054822T3 (es) * 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.

Also Published As

Publication number Publication date
JPH03254678A (ja) 1991-11-13
AU6020190A (en) 1991-09-05
AU629966B2 (en) 1992-10-15
ES2075881T3 (es) 1995-10-16
EP0445460B1 (de) 1995-06-14
EP0445460A1 (de) 1991-09-11
JP2888586B2 (ja) 1999-05-10
DK0445460T3 (da) 1995-08-14
US5206155A (en) 1993-04-27
ATE123805T1 (de) 1995-06-15
CA2023114A1 (en) 1991-09-06
DE69020138T2 (de) 1995-12-14
US5369021A (en) 1994-11-29
NZ234741A (en) 1992-03-26
CA2023114C (en) 1996-12-17

Similar Documents

Publication Publication Date Title
DE69716767T2 (de) Verfahren zur herstellung von tolterodin
DE69020138D1 (de) Mikroorganismus zur selektiven Herstellung einer spezifischen Komponente von Avermectin und Verfahren zu deren selektiven Herstellung.
DE69311000T2 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
DE59300243D1 (de) Verfahren zur Herstellung von 3,5-Difluoranilin.
DE3853548D1 (de) Verfahren zur Herstellung von Verbindungen mit einer Hydroxyl- oder Epoxy-Endgruppe und Mikroorganismen dafür.
DE69427955T2 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE69006911T2 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
ATE127523T1 (de) Verfahren zur biologischen herstellung einer hydroxyvitamin-d-verbindung.
ATE107656T1 (de) Verfahren zur herstellung von 14-alpha-hydroxy-4- androsten-3,6,17, trion.
ATE154008T1 (de) Lacton-verbindung und verfahren zu ihrer herstellung
DE69404953T2 (de) Verfahren zur Herstellung von AZT und Derivaten davon
NO178235C (no) Fremgangsmåte for mikrobiologisk fremstilling av L-carnitin
DE3785537T2 (de) Mikroorganismus und verfahren zur herstellung von oxydationsverbindungen mit diesem mikroorganismus.
DE3781192T2 (de) Mikroorganismus, esterase und verfahren zu deren herstellung.
DE69326050D1 (de) Verfahren zur Herstellung von 0,0'-Diacylweinsäureanhydrid und Verfahren zur Herstellung von 0,0'-Diacylweinsäure
DE69218067D1 (de) Verfahren zur Herstellung von 3-deacylierten Derivaten eines 16-gliedrigen Macrolid-Antibiotikums, hierfür verwendeter Mikroorganismus, sowie neues Macrolid-Antibiotikum
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.
ES2045146T3 (es) Avermectinas etiladas.
ATE93832T1 (de) Verfahren zur herstellung von 4,6-dimethyl-7hydroxynonan-3-on.
ATE263180T1 (de) Verfahren zur desmethylierung von erythromycinen und deren derivaten
ATE144285T1 (de) Mikrobiologisches verfahren zur herstellung von 5-hydroxy-2-pyrazincarbonsäure
DE59605866D1 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
DE59300849D1 (de) Verfahren zur Herstellung eines Gemisches von 6-(2,6,6 Trimethyl-cyclohex-1-en-1-yl)-4-methyl-hex-3-en-1-ol und -4-en-1-ol.
DE68910806D1 (de) Verfahren zur Herstellung von 4,4'''-Dihydroxyquaterphenyl oder deren Derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee